Second Oral Antibiotic for Gonorrhea Gets FDA Green Light

(MedPage Today) — The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication.
Zoliflodacin is the first of a new class of antibiotics…

Want to go deeper? Ask Sophie 🤔

Have a question about what you just read? Type below or click a suggestion, and Sophie will continue the conversation.

Try asking:

Share this Post

More Posts

Subscribe to our Newsletter
Executive Orders
Modifying the Scope of Reciprocal Tariffs and Establishing Procedures for Implementing Trade and Security Agreements
Restoring the United States Department of War
Strengthening Efforts To Protect U.S. Nationals From Wrongful Detention Abroad
Implementing the United States-Japan Agreement
Latest Posts
Public Health
Germany Sharply Rejects RFK Jr.’s Claims That It Prosecutes Docs for Vax Exemptions
Public Health
Germany Sharply Rejects RFK Jr.’s Claims That It Prosecutes Docs for Vax Exemptions
Public Health
Germany Sharply Rejects RFK Jr.’s Claims That It Prosecutes Docs for Vax Exemptions
Public Health
Germany Sharply Rejects RFK Jr.’s Claims That It Prosecutes Docs for Vax Exemptions
Become a Contributor
Public Health Disciplines
Menu
Hi, I’m SOPHie
Sophie Avatar SOPHie – Public Health Assistant
Powered by ChatGPT + Verified Sources